Streetbeat News

Price Targets

PRE

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Prenetics Global (NASDAQ:PRE) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:50 pm

PACB

Cantor Fitzgerald analyst Ross Osborn has reiterated a Neutral rating on Pacific Biosciences (NASDAQ:PACB) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:49 pm

NYXH

Cantor Fitzgerald analyst Steven Halper has reiterated an Overweight rating on Nyxoah (NASDAQ:NYXH) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:48 pm

NNOX

Cantor Fitzgerald analyst Steven Halper has reiterated an Overweight rating on Nano X Imaging (NASDAQ:NNOX) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:47 pm

MYNZ

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Mainz Biomed (NASDAQ:MYNZ) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:46 pm

LUCD

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Lucid Diagnostics (NASDAQ:LUCD) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:45 pm

ELUT

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Elutia (NASDAQ:ELUT) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:44 pm

AXGN

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Axogen (NASDAQ:AXGN) and maintained a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:42 pm

AWH

Cantor Fitzgerald analyst Ross Osborn has reiterated a Neutral rating on Aspira Womens Health (NASDAQ:AWH) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:39 pm

GKOS

Stifel analyst Thomas Stephan has reiterated a 'Buy' rating on Glaukos (NYSE:GKOS) and maintained a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:37 pm